{"entity":{"id":"rejuv-life-return-to-work","kind":"technology","name":"Going back to work after cancer: the rates, and the programmes that change them","aka":[],"tldr":"Pooled across 36 studies, 20,366 people who had had cancer and 157,603 controls, 33.8 per cent of those who had had cancer were unemployed against 15.2 per cent, a relative risk of 1.37. Of four kinds of return-to-work programme tested in trials, exercise and multidisciplinary ones each raised the proportion returning by about a quarter; education alone did not.","summary":"The size of the problem. A meta-analysis and meta-regression pooled 36 studies published between 1966 and 2008, 16 from the United States, 15 from Europe and 5 elsewhere, covering 20,366 people who had had cancer and 157,603 healthy controls. Overall, 33.8 per cent of survivors were unemployed against 15.2 per cent of controls, a pooled relative risk of 1.37 (95 per cent confidence interval 1.21 to 1.55). By cancer: breast 35.6 against 31.7 per cent (relative risk 1.28), gastrointestinal cancers 48.8 against 33.4 per cent (1.44), cancers of the female reproductive organs 49.1 against 38.3 per cent (1.28). Three groups showed no significant excess: blood cancers (30.6 against 23.7 per cent, 1.41 with a confidence interval crossing one), prostate cancer (39.4 against 27.1 per cent, 1.11) and testicular cancer (18.5 against 18.1 per cent, 0.94). The meta-regression examined cancer type, country, average age at diagnosis and the background unemployment rate as explanations for the variation between studies.\n\nWhat changes it. The Cochrane review of non-medical interventions, updated in 2024, included 15 randomised trials covering 1,477 people. All were conducted in high-income countries and most concerned breast cancer (nine trials) or prostate cancer (two). Nine trials were judged at low risk of bias and six at high risk, most often because of a lack of blinding, which is difficult to avoid in this kind of trial.\n\nThe results by type of programme, with the review's own certainty ratings:\n\nPsycho-educational interventions, meaning patient education and counselling: \"probably result in little to no difference in RTW compared to care as usual\", relative risk 1.09 (0.96 to 1.24), 4 trials, 512 participants, moderate-certainty evidence. About 625 per 1,000 participants returned to work in both arms.\n\nVocational interventions: one trial of 34 participants, relative risk 0.94 (0.78 to 1.13), very low-certainty evidence. The review's phrase is \"The evidence was very uncertain\", which is the honest summary of a single trial of 34 people.\n\nPhysical interventions, meaning walking, yoga or structured exercise: \"likely increase RTW compared to care as usual\", relative risk 1.23 (1.08 to 1.39), 4 trials, 434 participants, moderate certainty. Translated by the review into absolute terms, probably 677 to 871 per 1,000 returned against 627 per 1,000 in the control group.\n\nMultidisciplinary interventions, combining vocational counselling, education, counselling and physical exercise: \"likely increase RTW\", relative risk 1.23 (1.09 to 1.33), 6 trials, 497 participants, moderate certainty, which is 694 to 844 per 1,000 against 625 per 1,000.\n\nQuality of life did not improve in any of the comparisons that measured it, with differences on the standard cancer quality-of-life questionnaire of 1.8 points and 1.4 points on a 100-point scale, both with confidence intervals crossing zero. That is worth stating directly: these programmes get more people back to work and have not been shown to make them feel better, and both halves of that matter when deciding whether to join one.\n\nWhat this means practically. The thing with the best evidence is the same thing that has the best evidence for fatigue, strength and, in colon cancer, survival: structured exercise, which has its own record in this front with the dose written down. A programme that combines exercise with vocational counselling does about as well. A leaflet and a conversation, on the current evidence, does not.\n\nWhat is missing, and it is a lot. Every trial was in a high-income country, so there is no evidence at all on return to work after cancer in low- and middle-income settings, where informal employment and the absence of sick pay make the question sharper. Two thirds of the trials were in breast or prostate cancer. The outcome measured is usually whether a person returned at 12 months, not whether they stayed, whether they returned to the same job, or whether they returned on terms they could sustain. And none of this literature covers self-employment, which is the situation in which a cancer diagnosis most directly removes income.","status":"established","asOf":"2026-10-02","wikipedia":"https://en.wikipedia.org/wiki/Vocational_rehabilitation","links":[{"label":"Cancer survivors and unemployment: a meta-analysis and meta-regression (JAMA 2009)","url":"https://doi.org/10.1001/jama.2009.187"},{"label":"Non-medical interventions to enhance return to work for people with cancer (Cochrane 2024)","url":"https://doi.org/10.1002/14651858.CD007569.pub4"},{"label":"Effectiveness of clinical healthcare interventions for enhancing the work participation of patients with various health conditions: a synthesis of systematic reviews (BMJ Open 2025)","url":"https://doi.org/10.1136/bmjopen-2024-094201"}],"tags":["rejuvenation","survivorship","evidence:moderate","psychosocial"],"related":["idea-acc-return-to-work-rehabilitation","work-and-money-breast-cancer-uk","lymphoma-living-returning-to-work"],"cancers":["breast-hr-positive","prostate","colorectal","testicular","hodgkin-lymphoma","dlbcl"],"sections":["rejuvenation","supportive-care"],"technologies":["rejuv-life-employment-rights-uk","rejuv-life-employment-rights-us","rejuv-life-money-after-treatment","exercise-prescription-after-cancer","structured-exercise-survivorship","cancer-related-fatigue-management","cognitive-impairment-after-cancer-treatment","survivorship-care-plan"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["cancer-related-fatigue","quality-of-life","late-effects"],"trials":[],"people":[],"bottlenecks":["b-survivorship"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"principle":"Return to work after cancer is limited by capacity and by arrangement, in that order. Fatigue, deconditioning, cognitive change and treatment schedules set what a person can do; hours, duties, travel and the employer's willingness to adjust set whether what they can do is enough for the job they have. Programmes built only on information address neither, which is consistent with the trial evidence that education alone changes nothing while exercise and multidisciplinary programmes change something.","strengths":["Pooled unemployment risk from 36 studies with healthy control groups","A Cochrane review that separates four programme types and rates certainty for each","The best-performing component, structured exercise, is cheap and already recommended for other reasons"],"limitations":["No trial evidence from low- or middle-income countries","Mostly breast and prostate cancer, and mostly measuring return at 12 months rather than staying","None of the programmes improved quality of life, and self-employment is not covered at all"]},"route":"/technologies/rejuv-life-return-to-work/","neighbours":{"idea":[{"id":"idea-acc-return-to-work-rehabilitation","kind":"idea","name":"Vocational rehabilitation integrated into cancer care so survivors can return to work","route":"/ideas/idea-acc-return-to-work-rehabilitation/"},{"id":"idea-rejuv-rehabilitation-prescription-at-discharge","kind":"idea","name":"Write a rehabilitation prescription at the end of treatment, and fund it like a drug","route":"/ideas/idea-rejuv-rehabilitation-prescription-at-discharge/"}],"term":[{"id":"cancer-related-fatigue","kind":"term","name":"Cancer-related fatigue (tiredness)","route":"/terms/cancer-related-fatigue/"},{"id":"financial-toxicity","kind":"term","name":"Financial toxicity","route":"/terms/financial-toxicity/"},{"id":"lymphoma-living-returning-to-work","kind":"term","name":"Going back to work after lymphoma, and the money in the meantime","route":"/terms/lymphoma-living-returning-to-work/"},{"id":"late-effects","kind":"term","name":"Late effects and survivorship toxicity","route":"/terms/late-effects/"},{"id":"quality-of-life","kind":"term","name":"Quality of life","route":"/terms/quality-of-life/"},{"id":"work-and-money-breast-cancer-uk","kind":"term","name":"Work and money during breast cancer treatment (UK)","route":"/terms/work-and-money-breast-cancer-uk/"}],"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"hodgkin-lymphoma","kind":"cancer","name":"Hodgkin lymphoma","route":"/cancers/hodgkin-lymphoma/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"},{"id":"testicular","kind":"cancer","name":"Testicular germ cell tumours","route":"/cancers/testicular/"}],"section":[{"id":"rejuvenation","kind":"section","name":"Recovery & Rejuvenation","route":"/fronts/rejuvenation/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"technology":[{"id":"rejuv-access-survivorship-care-germany","kind":"technology","name":"After treatment in Germany: a rehabilitation entitlement, not a leaflet","route":"/technologies/rejuv-access-survivorship-care-germany/"},{"id":"rejuv-access-survivorship-care-uk","kind":"technology","name":"After treatment in the UK: personalised care, and follow-up you lead yourself","route":"/technologies/rejuv-access-survivorship-care-uk/"},{"id":"rejuv-life-employment-rights-uk","kind":"technology","name":"Employment rights with cancer in the United Kingdom","route":"/technologies/rejuv-life-employment-rights-uk/"},{"id":"rejuv-life-employment-rights-us","kind":"technology","name":"Employment rights with cancer in the United States","route":"/technologies/rejuv-life-employment-rights-us/"},{"id":"cancer-related-fatigue-management","kind":"technology","name":"Fatigue after cancer treatment: what actually works","route":"/technologies/cancer-related-fatigue-management/"},{"id":"rejuv-mind-body-after-stoma-and-limb-loss","kind":"technology","name":"Living with a stoma, and living after an amputation","route":"/technologies/rejuv-mind-body-after-stoma-and-limb-loss/"},{"id":"rejuv-life-money-after-treatment","kind":"technology","name":"Money after treatment: what the cost of cancer does once the treatment has finished","route":"/technologies/rejuv-life-money-after-treatment/"},{"id":"structured-exercise-survivorship","kind":"technology","name":"Structured exercise programmes after curative treatment","route":"/technologies/structured-exercise-survivorship/"},{"id":"survivorship-care-plan","kind":"technology","name":"Survivorship care and late-effects surveillance","route":"/technologies/survivorship-care-plan/"},{"id":"exercise-prescription-after-cancer","kind":"technology","name":"The exercise prescription after cancer: the dose the guidelines state","route":"/technologies/exercise-prescription-after-cancer/"},{"id":"cognitive-impairment-after-cancer-treatment","kind":"technology","name":"Thinking and memory after cancer treatment: what is measurable, and what helps","route":"/technologies/cognitive-impairment-after-cancer-treatment/"}],"bottleneck":[{"id":"rejuv-agenda-rehabilitation-not-commissioned","kind":"bottleneck","name":"Rehabilitation is recommended everywhere and commissioned almost nowhere","route":"/bottlenecks/rejuv-agenda-rehabilitation-not-commissioned/"},{"id":"b-survivorship","kind":"bottleneck","name":"Survivorship and late effects are neglected","route":"/bottlenecks/b-survivorship/"}],"roadmap":[{"id":"rejuvenation-roadmap","kind":"roadmap","name":"Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it","route":"/roadmaps/rejuvenation-roadmap/"}],"trial":[{"id":"rejuv-trial-canwork","kind":"trial","name":"CanWork: an occupational therapy programme to help women return to work after breast cancer","route":"/trials/rejuv-trial-canwork/"}]}}